Centers for Disease Control and Prevention
cdc.govLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
296
Active
6
Phase 3
46
Total enrollment
2,245,807
Pipeline matrix
Showing 14 of 14 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Moxifloxacin | — | — | — | — | 5 | ||
| Delamanid | — | — | — | — | — | 1 | |
| Bedaquiline | — | — | — | — | — | 1 | |
| Rifapentine daily for 6 weeks | — | — | — | — | — | 1 | |
| Rifapentine and Isoniazid weekly for 12 weeks | — | — | — | — | — | 1 | |
| Rifampin and Isoniazid daily for 12 weeks | — | — | — | — | — | 1 | |
| Rifampin daily for 16 weeks | — | — | — | — | — | 1 | |
| Isoniazid | — | — | 10 | ||||
| Rifampin | — | — | — | 5 | |||
| Rifabutin | — | — | 5 | ||||
| Pyrazinamide | — | — | — | — | 3 | ||
| Ethambutol | — | — | — | — | 3 | ||
| 3.75 µg Dose of CDC-9 Inactivated Rotavirus Vaccine | — | — | — | — | — | 2 | |
| 7.5 µg Dose of CDC-9 Inactivated Rotavirus Vaccine | — | — | — | — | — | 2 |
Next readouts
- 2026-10-06
- 2026-12-31
- 2029-12-31
Top conditions
- HIV Infections39
- Malaria23
- Tuberculosis20
- HIV20
- Poliomyelitis15
- Influenza12
- Sexually Transmitted Diseases11
- Arthritis8
Frequently asked questions about Centers for Disease Control and Prevention
- How many clinical trials does Centers for Disease Control and Prevention have on ClinicalTrials.gov?
- Centers for Disease Control and Prevention is listed as the lead sponsor on 296 clinical trials in ClinicalTrials.gov, 6 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Centers for Disease Control and Prevention's trials are in Phase 3?
- 46 of Centers for Disease Control and Prevention's trials are in Phase 3, spread across 14 active drug programs.
- What therapeutic areas does Centers for Disease Control and Prevention focus on?
- Centers for Disease Control and Prevention's most-studied conditions on ClinicalTrials.gov are HIV Infections, Malaria, Tuberculosis, HIV, Poliomyelitis.
- When are Centers for Disease Control and Prevention's next clinical trial readouts?
- Centers for Disease Control and Prevention has 3 upcoming primary-completion readouts tracked here; the soonest is “CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults”, expected around 2026-10-06.